{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:06Z","timestamp":1787010186820,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To summarize recent evidence from randomized clinical trials (RCT) and meta-analysis of patent ductus arteriosus (PDA) closure therapies versus conservative\/expectant management on key outcomes such as bronchopulmonary dysplasia (BPD) or death in very preterm (&lt;32 weeks\u2019 gestation) infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Of 10 completed RCTs in the past decade of medical therapies before 2 weeks of age to close a PDA, none demonstrated benefit in reducing moderate\u2013severe BPD\/death by 36 weeks postmenstrual age as compared to placebo treatment. When combined, the meta-analysis of the 10 RCTs showed an elevated risk of BPD\/death [relative risk (RR): 1.10, 95% confidence interval (CI), 1.01\u20131.19) and higher risk of death by 36 weeks postmenstrual age or discharge (RR: 1.25; 95% CI, 1.01\u20131.56). A 2025 Cochrane meta-analysis also found a similar concerning trend of increased mortality following early medical treatment for PDA. Despite their recent popularity, there are no published trials demonstrating safety or efficacy of transcatheter PDA closure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>We now have ample evidence for all clinicians to finally acknowledge that conservative PDA management is the correct path forward. Clinical experimentation is no longer acceptable, and expectant PDA management must be adopted as the current standard if we are to adhere to our foundational principle, \u2018first, do no harm\u2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001543","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:00:49Z","timestamp":1769076049000},"page":"200-206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Patent ductus arteriosus: emerging trial evidence firmly supports conservative management in preterm infants"],"prefix":"10.1097","volume":"38","author":[{"given":"Nehal A.","family":"Parikh","sequence":"first","affiliation":[{"name":"The Perinatal Institute"},{"name":"Neurodevelopmental Disorders Prevention Center, Cincinnati Children's Hospital Medical Center"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Velu","sequence":"additional","affiliation":[{"name":"The Perinatal Institute"},{"name":"Neurodevelopmental Disorders Prevention Center, Cincinnati Children's Hospital Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"R1-20260304","doi-asserted-by":"crossref","first-page":"41.e6","DOI":"10.1016\/j.jpeds.2018.09.012","article-title":"PDA-TOLERATE Trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age","volume":"205","author":"Clyman","year":"2019","journal-title":"J Pediatr"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"33.e2","DOI":"10.1016\/j.jpeds.2020.12.008","article-title":"Effect of early targeted treatment of ductus arteriosus with ibuprofen on survival without cerebral palsy at 2 years in infants with extreme prematurity: a randomized clinical trial","volume":"233","author":"Roz\u00e9","year":"2021","journal-title":"J Pediatr"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMoa2207418","article-title":"Expectant management or early ibuprofen for patent ductus arteriosus","volume":"388","author":"Hundscheid","year":"2023","journal-title":"N Engl J Med"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/a-1782-5860","article-title":"Randomized noninferiority trial of expectant management versus early treatment of patent ductus arteriosus in preterm infants","volume":"41","author":"Potsiurko","year":"2024","journal-title":"Am J Perinatol"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa2305582","article-title":"Trial of selective early treatment of patent ductus arteriosus with ibuprofen","volume":"390","author":"Gupta","year":"2024","journal-title":"N Engl J Med"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamapediatrics.2025.1025","article-title":"Active treatment vs expectant management of patent ductus arteriosus in preterm infants: a meta-analysis","volume":"179","author":"Buvaneswarran","year":"2025","journal-title":"JAMA Pediatr"},{"key":"R7-20260304","first-page":"CD013278","article-title":"Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants","volume":"12","author":"Mitra","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20260304","first-page":"CD013133","article-title":"Indomethacin for symptomatic patent ductus arteriosus in preterm infants","volume":"1","author":"Evans","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/NPM-17130","article-title":"Presymptomatic targeted treatment of patent ductus arteriosus in preterm newborns: a systematic review and meta-analysis","volume":"12","author":"Farooqui","year":"2019","journal-title":"J Neonatal Perinatal Med"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_8_21","article-title":"Evolution of surgical repair of patent ductus arteriosus - a historical timeline","volume":"22","author":"Murshid","year":"2021","journal-title":"Heart Views"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"151723","DOI":"10.1016\/j.semperi.2023.151723","article-title":"A historical perspective of investigations into the mechanisms and management of patent ductus arteriosus","volume":"47","author":"Shelton","year":"2023","journal-title":"Semin Perinatol"},{"key":"R12-20260304","doi-asserted-by":"crossref","first-page":"e20201209","DOI":"10.1542\/peds.2020-1209","article-title":"Patent ductus arteriosus of the preterm infant","volume":"146","author":"Hamrick","year":"2020","journal-title":"Pediatrics"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"e2025071425","DOI":"10.1542\/peds.2025-071425","article-title":"Patent ductus arteriosus in preterm infants","volume":"155","author":"Ambalavanan","year":"2025","journal-title":"Pediatrics"},{"key":"R14-20260304","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41390-025-03820-9","article-title":"Beneficial vs harmful effects of pharmacological treatment of patent ductus arteriosus: a Bayesian meta-analysis","volume":"98","author":"Villamor","year":"2025","journal-title":"Pediatr Res"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations","volume":"35","author":"Arnall Patz","year":"1952","journal-title":"Am J Ophthalmol"},{"key":"R16-20260304","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1542\/peds.109.2.330","article-title":"Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants","volume":"109","year":"2002","journal-title":"Pediatrics"},{"key":"R17-20260304","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/apc.apc_118_24","article-title":"Exploring the relation between patent ductus arteriosus and bronchopulmonary dysplasia: insights from national inpatient sample","volume":"17","author":"Abbas","year":"2024","journal-title":"Ann Pediatr Cardiol"},{"key":"R18-20260304","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-025-04067-0","article-title":"Association of patent ductus arteriosus duration with bronchopulmonary dysplasia and mortality: a cohort study","author":"Bonafiglia","year":"2025","journal-title":"Pediatr Res"},{"key":"R19-20260304","first-page":"CD001146","article-title":"Early (<8\u200adays) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"10","author":"Doyle","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20260304","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00431-019-03398-5","article-title":"Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis","volume":"178","author":"Morris","year":"2019","journal-title":"Eur J Pediatr"},{"key":"R21-20260304","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N Engl J Med"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.13089","article-title":"Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates","volume":"83","author":"Kua","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"R23-20260304","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","article-title":"Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia","volume":"191","author":"Mourani","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20260304","doi-asserted-by":"crossref","article-title":"Clinical significance of early pulmonary hypertension in preterm infants","author":"Arjaans","DOI":"10.1016\/j.jpeds.2022.07.039"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1203\/00006450-199912000-00007","article-title":"The new BPD: an arrest of lung development","volume":"46","author":"Jobe","year":"1999","journal-title":"Pediatr Res"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/archdischild-2024-327169","article-title":"Association between early pulmonary arterial pressure measurements and bronchopulmonary dysplasia or mortality in very preterm infants: a prospective cohort study","volume":"110","author":"Akin","year":"2025","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R27-20260304","doi-asserted-by":"crossref","first-page":"e022776","DOI":"10.1161\/JAHA.121.022776","article-title":"Trend and outcomes for surgical versus transcatheter patent ductus arteriosus closure in neonates and infants at US Children's Hospitals","volume":"11","author":"Kuntz","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R28-20260304","doi-asserted-by":"crossref","first-page":"104418","DOI":"10.1016\/j.phrs.2019.104418","article-title":"Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: a systematic review and network meta-analysis of clinical trials and observational studies","volume":"148","author":"Marconi","year":"2019","journal-title":"Pharmacol Res"},{"issue":"(S 01)","key":"R29-20260304","first-page":"e1759","article-title":"Patent ductus arteriosus response to treatment by course and associations with perinatal and clinical factors","volume":"41","author":"Rutledge","year":"2024","journal-title":"Am J Perinatol"},{"key":"R30-20260304","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00246-018-1967-8","article-title":"Incidence, risk factors, and comorbidities of vocal cord paralysis after surgical closure of a patent ductus arteriosus: a meta-analysis","volume":"40","author":"Henry","year":"2019","journal-title":"Pediatr Cardiol"},{"key":"R31-20260304","doi-asserted-by":"crossref","first-page":"F227","DOI":"10.1136\/archdischild-2017-313161","article-title":"Early surgery and neurodevelopmental outcomes of children born extremely preterm","volume":"103","author":"Hunt","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R32-20260304","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2016.06.046","article-title":"Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants","volume":"177","author":"Sung","year":"2016","journal-title":"J Pediatr"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:00:56Z","timestamp":1772607656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001543","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}